InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: None

Friday, 02/01/2019 8:43:32 AM

Friday, February 01, 2019 8:43:32 AM

Post# of 48316
PISCES trial showing progress. 24% BORR is above the 20% bar for approval. Oncosec is turning into an Orphan Drug Company with pipeline expansion. Very likely to see a buyout before end of PISCES trial....Merck (combo studies with Oncosec growing)